ABC Related Analyst Ratings
-
AmerisourceBergen (ABC) Likely to Score Another Win Against McKesson (MCK)
-
Baird Downgrades AmerisourceBergen (ABC) to Neutral
-
AmerisourceBergen (ABC) Not Fully Reflecting Walgreens Deal - Goldman Sachs
-
Express Scripts (ESRX) Pricing Aggressively, Leerink Swann Maintains Buy
-
Citi Upgrades AmerisourceBergen (ABC) to Buy
-
ISI Group Downgrades AmerisourceBergen (ABC) to Neutral
-
With Walgreen (WAG) Deal in Bag, AmerisourceBergen (ABC) Could Be Takeout Target
-
UBS Downgrades AmerisourceBergen (ABC) to Neutral
-
ISI Group Downgrades AmerisourceBergen (ABC) to Buy
-
Mizuho Securities Downgrades AmerisourceBergen (ABC) to Neutral
-
Goldman Sachs Downgrades AmerisourceBergen (ABC) to Neutral, Removes from CL
-
Leerink Swann Downgrades AmerisourceBergen (ABC) to Market Perform; Headwinds Remove Positive N-T Catalysts
-
Baird Upgrades AmerisourceBergen (ABC) to Outperform
-
ISI Group Starts AmerisourceBergen (ABC) at Overweight
-
Mizuho Securities Starts AmerisourceBergen (ABC) at Buy
-
Goldman Sachs Adds AmerisourceBergen (ABC) to Conviction Buy, Removes McKesson (MCK)
-
Barclays on U.S. Health Care Distribution & Technology: Earnings Preview on ABC, MCK and CAH
-
Morgan Stanley Downgrades AmerisourceBergen (ABC) to Equalweight
-
Baird Downgrades AmerisourceBergen (ABC) to Neutral
-
UBS Maintains a 'Buy' on AmerisourceBergen (ABC); Lower F2013-14 EPS For Generics + Medco
-
Barclays on U.S. Health Care Distribution & Technology: VA Contract Announcement Could Be Early January; No Change in Our Expectations
-
Goldman Sachs Deletes AmerisourceBergen (ABC) from Conviction Buy List
-
Goldman Sachs Adds McKesson (MCK) to Conviction Buy List
-
Barclays Maintains an 'Overweight' on AmerisourceBergen (ABC); Gemcitabine pricing assumptions help our Q4, F12 Q1
-
Stifel Nicolaus Upgrades AmerisourceBergen (ABC) to Buy
-
Goldman Sachs Adds 13% of the DJIA To its Conviction Buy List In Past Two Days
-
Goldman Sachs added AmerisourceBergen (ABC) to Conviction Buy
-
Citi Downgrades AmerisourceBergen (ABC) to Hold
-
Raymond James Upgrades AmerisourceBergen (ABC) to Strong Buy
-
Barclays on U.S. Health Care Distribution & Technology: Pharmaceutical Supply Chain: Constructive Tone Confirmed with June Qtr Preview
-
Goldman Sachs Removes AmerisourceBergen (ABC) from Conviction Buy List
-
AmerisourceBergen (ABC) Seen Taking a Hit from MedcoHealth Contract Loss
-
Cowen Starts Healthcare Stocks: ESRX, MHS, MDRX, CAH, MCK, ABC at Outperform, CERN, SXCI, QSII at Neutral
-
Barclays Maintains an 'Overweight' on AmerisourceBergen (ABC); Raising Estimates
-
UBS Maintains a 'Buy' on McKesson (MCK); Q4 Earnings Preview
-
UBS Maintains a 'Buy' on AmerisourceBergen (ABC); Specialty Distribution Paying Dividends
-
Barclays Maintains an 'Overweight' on AmerisourceBergen (ABC); 'Specialty Lift Ahead': In-Line Q1 Leads Us to Lift FY11 Estimate
-
UBS on U.S. Healthcare Distribution: 2011 Outlook and Quarterly Preview
-
Barclays Maintains an 'Overweight' Rating on AmerisourceBergen (ABC); Analyst Day Prep - 10K Review Highlights Medco Health Growth
-
Goldman Sachs Upgrades AmerisourceBergen (ABC) to Conviction Buy
-
Susquehanna Feels Positive on Amerisource Bergen (ABC)
-
UPDATE - UBS Downgrades Omnicare (OCR) to Neutral; Moving To The Sidelines Post +25% Rally
-
Leerink Swann Initiates Coverage on AmerisourceBergen (ABC); Specialty Generics, Brand Inflation and Financial Discipline
-
Citi Maintains a 'Buy' on AmerisourceBergen (ABC); Fundamentals Remain Strong
-
Goldman Sachs Raises Targets On MCK, ABC, CAH
-
UBS Maintains a 'Buy' on AmerisourceBergen (ABC); Knocks the Cover Off the Ball Again
-
Citi maintains a 'Buy' on AmerisourceBergen (ABC); Making it Look as Easy as A-B-C
-
Susquehanna Initiates Coverage on PharMerica Corp (PMC) with a Neutral
-
Citi Assumes Coverage on Pharmacy Benefit Management & Distribution Stocks
-
Citi Upgrades AmerisourceBergen (ABC) to Buy
Back to ABC Stock Lookup
